Fieldpoint Private Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-800
Closed -$153K 630
2019
Q4
$153K Hold
800
0.04% 293
2019
Q3
$135K Hold
800
0.05% 248
2019
Q2
$134K Sell
800
-627
-44% -$86.8K 0.04% 283
2019
Q1
$209K Sell
1,427
-1,603
-53% -$232K 0.09% 189
2018
Q4
$405K Sell
3,030
-1,265
-29% -$207K 0.18% 141
2018
Q3
$818K Buy
4,295
+2,868
+201% +$527K 0.31% 96
2018
Q2
$238K Hold
1,427
0.09% 193
2018
Q1
$240K Hold
1,427
0.11% 155
2017
Q4
$233K Hold
1,427
0.12% 154
2017
Q3
$292K Buy
+1,427
New +$332K 0.13% 161
2017
Q2
Sell
-1,427
Closed -$341K 346
2017
Q1
$341K Buy
+1,427
New +$332K 0.26% 78

Other funds holding AGN

Fieldpoint Private Securities's AGN Position: Q1 2020 in Review

Fieldpoint Private Securities sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 800 shares — an estimated $153K sold.

Fieldpoint Private Securities first reported a position in AGN in Q1 2017 and held it in 11 quarters. The position peaked at $818K in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Fieldpoint Private Securities reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Fieldpoint Private Securities sold 800 Allergan plc shares in Q1 2020, an estimated $153K.
  • Fieldpoint Private Securities first reported a position in Allergan plc in Q1 2017 and held it in 11 quarters.
  • Fieldpoint Private Securities's Allergan plc position peaked at $818K in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Fieldpoint Private Securities's 13F filing for Q1 2020, filed 11 May 2020.